Ledger.Open graph →
SEC Form D · filed February 17, 2022

MorphImmune Inc

Offering
$19.0M
Sold
$17.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WEST LAFAYETTE, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sunil Singhal, M.D · West Lafayette, INDirectorPhilip Low, Ph.D · West Lafayette, INDirectorIsaac Barchas · West Lafayette, INDirectorRonald Martell · West Lafayette, INExec · DirectorRachel Stack · Denver, CODirectorDuane Strite · Hephzibah, GAExec · DirectorBill Fathers · Denver, CODirectorSimon Barnes · Grand Duchy of Luxembourg, LuxembourgDirectorPatrick Bartels · Fort Lauderdale, FLDirectorJim Grady · Fort Lauderdale, FLDirectorPeter Kim · Irvine, CADirectorKyle Mckuhen · Salt Lake City, UTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗